Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8350736 | Pharmacology Biochemistry and Behavior | 2015 | 7 Pages |
Abstract
The results of this study demonstrated that the injection of Aβ25-35 resulted in impaired LTP and the memory process, which is likely mediated through increasing the release probability of neurotransmitter vesicles. In addition, treatment with Epo improved the Aβ-induced deficits in memory and LTP induction, probably via recovering the release probability.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Parisa Esmaeili Tazangi, Seyed Mostafa Shid Moosavi, Mohamad Shabani, Masoud Haghani,